TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of IN.PACT (Paclitaxel) Admiral Drug-Coated Balloon (DCB) vs. Standard Percutaneous Transluminal Angioplasty (PTA) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Brief Summary: The purpose of the study is to demonstrate the safety and efficacy of the IN.PACT Admiral drug-coated balloon (DCB) in comparison to any standard balloon for treatment of peripheral arterial disease (PAD) in the superficial femoral artery and proximal popliteal artery.


Options:
A: Arm Label: Drug-Coated Balloon (DCB); Type: EXPERIMENTAL; Interventions: Device: Drug-Coated Balloon (DCB) | Arm Label: Standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: PTA Balloon: Balloon Angioplasty | Intervention Type: DEVICE; Name: Drug-Coated Balloon (DCB); Assigned to Arm(s): Drug-Coated Balloon (DCB) | Intervention Type: DEVICE; Name: PTA Balloon: Balloon Angioplasty; Assigned to Arm(s): Standard PTA
B: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Device: paclitaxel coated balloon catheter (device with drug) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: paclitaxel coated balloon catheter (device with drug) | Intervention Type: DEVICE; Name: paclitaxel coated balloon catheter (device with drug); Assigned to Arm(s): 1, 2
C: Arm Label: DEB; Type: N/A; Interventions: Device: DEB | Arm Label: conventional PTA; Type: N/A; Interventions: Device: POBA | Intervention Type: DEVICE; Name: DEB; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: POBA; Assigned to Arm(s): conventional PTA
D: Arm Label: Stent; Type: EXPERIMENTAL; Interventions: Device: Zilver® PTX™ Stent | Intervention Type: DEVICE; Name: Zilver® PTX™ Stent; Assigned to Arm(s): Stent

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of The Pharmaceutical Care on the Quality of Life of Patients With Chagas Disease and Heart Failure: Randomized Clinical Trial
Brief Summary: The investigators hypothesize that pharmaceutical care may constitute an important tool for the clinical management of these patients by improving their compliance to their treatment with consequent improvement in their quality of life by minimizing symptoms, and decreasing the number of hospital admissions and adverse drug reactions. Therefore, the aim of this trial is to evaluate the contribution of pharmaceutical care to clinical treatment of patients with Chagas heart disease complicated by heart failure.

Study Type: Interventional

Study Design: A total of 88 patients will be randomly assigned into two parallel groups: (1) group who will receive standard care and pharmaceutical care; and (2) group who will receive only standard care. Both groups will be subjected to a follow-up period of 12 months. The primary outcome of this trial is the evaluation of quality of life, measured by the 36-item short-form and the Minnesota Living with Heart Failure Questionnaire. Secondary outcomes include drug-related problems and exercise tolerance measured by the standard six-minute walk test.


Options:
A: Intervention Type: BEHAVIORAL; Name: Home BP;secure messaging;pharmaceutical care;; Assigned to Arm(s): N/A
B: Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard care | Arm Label: Standard Care and Pharmaceutical Care; Type: OTHER; Interventions: Other: Standard care and Pharmaceutical care | Intervention Type: OTHER; Name: Standard care and Pharmaceutical care; Assigned to Arm(s): Standard Care and Pharmaceutical Care | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard Care
C: Arm Label: Feedback; Type: EXPERIMENTAL; Interventions: Device: Feedback | Arm Label: Demonstration; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Feedback; Assigned to Arm(s): Feedback | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Demonstration
D: Arm Label: Health service provision; Type: EXPERIMENTAL; Interventions: Procedure: Pharmacist-Initiated Intervention in OsteoArthritis (PhIT-OA) | Intervention Type: PROCEDURE; Name: Pharmacist-Initiated Intervention in OsteoArthritis (PhIT-OA); Assigned to Arm(s): Health service provision

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of The Pharmaceutical Care on the Quality of Life of Patients With Chagas Disease and Heart Failure: Randomized Clinical Trial
Brief Summary: The investigators hypothesize that pharmaceutical care may constitute an important tool for the clinical management of these patients by improving their compliance to their treatment with consequent improvement in their quality of life by minimizing symptoms, and decreasing the number of hospital admissions and adverse drug reactions. Therefore, the aim of this trial is to evaluate the contribution of pharmaceutical care to clinical treatment of patients with Chagas heart disease complicated by heart failure.

Study Type: Interventional

Study Design: A total of 88 patients will be randomly assigned into two parallel groups: (1) group who will receive standard care and pharmaceutical care; and (2) group who will receive only standard care. Both groups will be subjected to a follow-up period of 12 months. The primary outcome of this trial is the evaluation of quality of life, measured by the 36-item short-form and the Minnesota Living with Heart Failure Questionnaire. Secondary outcomes include drug-related problems and exercise tolerance measured by the standard six-minute walk test.


Options:
A: Arm Label: PHCVRS intervention; Type: EXPERIMENTAL; Interventions: Other: PHCVRS Intervention, Other: Personal Health Record | Arm Label: Usual care/Personal Health Record; Type: OTHER; Interventions: Other: Personal Health Record | Intervention Type: OTHER; Name: PHCVRS Intervention; Assigned to Arm(s): PHCVRS intervention | Intervention Type: OTHER; Name: Personal Health Record; Assigned to Arm(s): PHCVRS intervention, Usual care/Personal Health Record
B: Arm Label: Pharmacist-Physician Collaborative Medication Management; Type: EXPERIMENTAL; Interventions: Other: Pharmacist-Physician Collaborative Medication Therapy Management | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmacist-Physician Collaborative Medication Therapy Management; Assigned to Arm(s): Pharmacist-Physician Collaborative Medication Management
C: Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard care | Arm Label: Standard Care and Pharmaceutical Care; Type: OTHER; Interventions: Other: Standard care and Pharmaceutical care | Intervention Type: OTHER; Name: Standard care and Pharmaceutical care; Assigned to Arm(s): Standard Care and Pharmaceutical Care | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard Care
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemonitors and pharmacy management; Type: EXPERIMENTAL; Interventions: Other: Telemonitors and pharmacy management | Intervention Type: OTHER; Name: Telemonitors and pharmacy management; Assigned to Arm(s): Telemonitors and pharmacy management

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BReast Feeding Attitude and Volume Optimization (BRAVO) Trial: A Randomized Breast Feeding Optimization Experiment
Brief Summary: This study aims to find out whether breast feeding optimization will increase breast feeding rates and to evaluate its effect on cardiovascular risk and general health of children.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Low Intensity; Type: OTHER; Interventions: Other: Telephone-based breastfeeding peer counseling | Arm Label: High Intensity; Type: ACTIVE_COMPARATOR; Interventions: Other: Telephone-based breastfeeding peer counseling | Intervention Type: OTHER; Name: Telephone-based breastfeeding peer counseling; Assigned to Arm(s): High Intensity, Low Intensity
B: Arm Label: Essential Health Care (EHC) only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mass media | Arm Label: EHC + Micronutrient Powders; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders, Behavioral: Mass media | Arm Label: EHC + BCC; Type: EXPERIMENTAL; Interventions: Behavioral: EHC + BCC, Behavioral: Mass media | Arm Label: EHC + BCC + Micronutrient powders; Type: EXPERIMENTAL; Interventions: Behavioral: EHC + BCC, Dietary Supplement: Micronutrient powders, Behavioral: Mass media | Intervention Type: BEHAVIORAL; Name: EHC + BCC; Assigned to Arm(s): EHC + BCC, EHC + BCC + Micronutrient powders | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders; Assigned to Arm(s): EHC + BCC + Micronutrient powders, EHC + Micronutrient Powders | Intervention Type: BEHAVIORAL; Name: Mass media; Assigned to Arm(s): EHC + BCC, EHC + BCC + Micronutrient powders, EHC + Micronutrient Powders, Essential Health Care (EHC) only
C: Arm Label: Breast feeding optimization; Type: EXPERIMENTAL; Interventions: Behavioral: Breast feeding optimization, Behavioral: Usual care | Arm Label: Usual/routine care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Breast feeding optimization; Assigned to Arm(s): Breast feeding optimization | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Breast feeding optimization, Usual/routine care
D: Arm Label: Family groups; Type: EXPERIMENTAL; Interventions: Behavioral: Family groups | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family groups; Assigned to Arm(s): Family groups

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Weight Management Interventions for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF): a Randomized Controlled Trial
Brief Summary: The primary aim of the study is to evaluate if weight management intervention for obese women (BMI≥30\<35 kg/m2) prior to IVF improves the outcome assessed as live birth per participating woman, as compared to women where no intervention was made.


Options:
A: Arm Label: Resveratrol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Resveratrol | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo pills | Intervention Type: DIETARY_SUPPLEMENT; Name: Resveratrol; Assigned to Arm(s): Resveratrol | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo pills; Assigned to Arm(s): Control
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PEPCI group; Type: EXPERIMENTAL; Interventions: Procedure: PEPCI | Intervention Type: PROCEDURE; Name: PEPCI; Assigned to Arm(s): PEPCI group
C: Arm Label: IVF only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Weight reduction treatment and IVF; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Low calorie diet treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Low calorie diet treatment; Assigned to Arm(s): Weight reduction treatment and IVF
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Arm Label: Intensive Dietary Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive Dietary Intervention | Intervention Type: BEHAVIORAL; Name: Intensive Dietary Intervention; Assigned to Arm(s): Intensive Dietary Intervention | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Weight Management Interventions for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF): a Randomized Controlled Trial
Brief Summary: The primary aim of the study is to evaluate if weight management intervention for obese women (BMI≥30\<35 kg/m2) prior to IVF improves the outcome assessed as live birth per participating woman, as compared to women where no intervention was made.


Options:
A: Arm Label: IVF only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Weight reduction treatment and IVF; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Low calorie diet treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Low calorie diet treatment; Assigned to Arm(s): Weight reduction treatment and IVF
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Arm Label: Intensive Dietary Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive Dietary Intervention | Intervention Type: BEHAVIORAL; Name: Intensive Dietary Intervention; Assigned to Arm(s): Intensive Dietary Intervention | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Low Glycemic Index Diet Group; Type: EXPERIMENTAL; Interventions: Other: Low Glycemic Index Diet Group | Arm Label: Conventional Diet Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Diet Group | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Low Glycemic Index Diet Group; Assigned to Arm(s): Low Glycemic Index Diet Group | Intervention Type: OTHER; Name: Conventional Diet Group; Assigned to Arm(s): Conventional Diet Group
D: Arm Label: BMI > 32; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Drug: Placebo | Arm Label: BMI </= 32; Type: EXPERIMENTAL; Interventions: Drug: Metformin + Clomiphene, Drug: Metformin, Drug: Clomiphene | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): BMI > 32 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BMI > 32 | Intervention Type: DRUG; Name: Metformin + Clomiphene; Assigned to Arm(s): BMI </= 32 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): BMI </= 32 | Intervention Type: DRUG; Name: Clomiphene; Assigned to Arm(s): BMI </= 32

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Different Interventions in Physical Activity Level and Co-morbidities in Women: Randomized, Controlled Study
Brief Summary: The purpose of this study is to evaluate the impact of different types of intervention on physical activity level and co-morbidities in women workers aged between 40 and 50 years. Method: A total of 195 sedentary women aged between 40 and 50 years and those who agreed to participate were randomized to one of the following interventions: GI = Control (n = 47), GII = Individual counseling (n = 53), GIII = Counseling group (n = 48); GIV = physical training set (n = 47). Were evaluated: Physical Activity level (steps number evaluated by a pedometer), quality of life (SF-36), body composition (BMI, waist circumference and bioelectrical impedance) and clinical variables (plasma glucose and blood pressure).


Options:
A: Intervention Type: BEHAVIORAL; Name: Walking 45 mins 2x p.w.; Assigned to Arm(s): N/A
B: Arm Label: control (C) group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: telemedical (TM) group; Type: EXPERIMENTAL; Interventions: Device: telemedical devices (weighing machine and step counter) | Arm Label: telemedical coaching (TMC) group; Type: EXPERIMENTAL; Interventions: Device: telemedical devices (weighing machine and step counter), Behavioral: care calls once per week for 12 weeks | Intervention Type: DEVICE; Name: telemedical devices (weighing machine and step counter); Assigned to Arm(s): telemedical (TM) group, telemedical coaching (TMC) group | Intervention Type: BEHAVIORAL; Name: care calls once per week for 12 weeks; Assigned to Arm(s): telemedical coaching (TMC) group
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Individual counseling; Type: EXPERIMENTAL; Interventions: Behavioral: individual counseling | Arm Label: group counseling; Type: EXPERIMENTAL; Interventions: Behavioral: group counseling | Arm Label: aerobic training; Type: EXPERIMENTAL; Interventions: Behavioral: aerobic training | Intervention Type: BEHAVIORAL; Name: individual counseling; Assigned to Arm(s): Individual counseling | Intervention Type: BEHAVIORAL; Name: group counseling; Assigned to Arm(s): group counseling | Intervention Type: BEHAVIORAL; Name: aerobic training; Assigned to Arm(s): aerobic training
D: Arm Label: LEAP intervention; Type: EXPERIMENTAL; Interventions: Behavioral: LEAP intervention | Arm Label: Control; Type: OTHER; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: LEAP intervention; Assigned to Arm(s): LEAP intervention | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Training Dual-Task Walking After Stroke: Effects on Attentional and Locomotor Control
Brief Summary: Community ambulation is a highly complex skill requiring the ability to adapt to increased environmental complexity and perform multiple tasks simultaneously. Deficits in dual-tasking may severely compromise the ability to participate fully in community living. Unfortunately, current rehabilitation practice for stroke fails to adequately address dual-task limitations; individuals with stroke continue to exhibit clinically significant dual-task costs on gait at discharge. As a result, many stroke survivors are living in the community with residual deficits that may increase disability in the real world and lead to falls with devastating consequences. To address this issue, the proposed study investigates the efficacy of dual-task gait training on attention allocation and locomotor performance in community-dwelling stroke survivors. Because walking in the real world often requires time-critical tasks and obstacle avoidance, the investigators will test the impact of dual-task gait training on cognitive-motor interference during walking at preferred speed and at maximal speed (Aim 1), and on locomotor control during obstacle negotiation (Aim 2). The investigators will also evaluate the effects of the intervention on community reintegration and participation (Aim 3).


Options:
A: Arm Label: Dual-task gait training; Type: EXPERIMENTAL; Interventions: Behavioral: Gait training | Arm Label: Single-task gait training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Gait training | Intervention Type: BEHAVIORAL; Name: Gait training; Assigned to Arm(s): Dual-task gait training, Single-task gait training
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Instruction in physical training program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Instruction in physical training program; Assigned to Arm(s): Intervention arm
C: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: FAST protocol; Type: EXPERIMENTAL; Interventions: Behavioral: FAST protocol | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual care | Intervention Type: BEHAVIORAL; Name: FAST protocol; Assigned to Arm(s): FAST protocol
D: Arm Label: Exercise recommendation; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise, Exercise recommendation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patterns of Physical Activity Levels in Patients With Bronchiectasis: Cross Sectional Study Using Quantitative Methodology
Brief Summary: The primary aim of this study is to examine the physical activity levels of patients with bronchiectasis.

Subsidiary aims are:

1. To examine whether there is a relationship between the physical activity levels of patients with bronchiectasis and clinical phenotype (disease severity, exercise capacity, quality of life or other symptoms of their disease). The investigators also want to explore the relationship between physical activity levels and readiness to change physical activity behaviour (stages of change, self-efficacy, decisional balance and processes of change).
2. To assess the feasibility and acceptability of the physical activity assessment tools: ActiGraph, ActivPAL, pedometer and the International Physical Activity Questionnaire.

Hypothesis:

Patients with bronchiectasis will have low levels of physical activity, and this is related to their clinical phenotype (disease severity, exercise capacity, quality of life and other symptoms of their disease) and also their readiness to change physical activity behaviour (stages of change, self-efficacy, processes of change and decisional balance).


Options:
A: Arm Label: Observational; Type: N/A; Interventions: N/A
B: Arm Label: Chest Physiotherapy; Type: EXPERIMENTAL; Interventions: Procedure: Chest physiotherapy | Arm Label: Chest Physiotherapy + Exercise Program; Type: EXPERIMENTAL; Interventions: Procedure: Chest Physiotherapy + Exercise Program | Intervention Type: PROCEDURE; Name: Chest physiotherapy; Assigned to Arm(s): Chest Physiotherapy | Intervention Type: PROCEDURE; Name: Chest Physiotherapy + Exercise Program; Assigned to Arm(s): Chest Physiotherapy + Exercise Program
C: Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Procedure: Pulmonary rehabilitation | Intervention Type: PROCEDURE; Name: Pulmonary rehabilitation; Assigned to Arm(s): Pulmonary rehabilitation | Intervention Type: PROCEDURE; Name: Pulmonary rehabilitation; Assigned to Arm(s): Pulmonary rehabilitation
D: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise

Answer: A